• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

MRI对比剂Gd-DO3A-Ether-Rhein的合成及其坏死亲和性研究

张立邦, 张东建, 高萌, 金乔梅, 吴天泽, 杨阳, 张健, 殷志琦

张立邦, 张东建, 高萌, 金乔梅, 吴天泽, 杨阳, 张健, 殷志琦. MRI对比剂Gd-DO3A-Ether-Rhein的合成及其坏死亲和性研究[J]. 中国药科大学学报, 2019, 50(4): 444-451. DOI: 10.11665/j.issn.1000-5048.20190409
引用本文: 张立邦, 张东建, 高萌, 金乔梅, 吴天泽, 杨阳, 张健, 殷志琦. MRI对比剂Gd-DO3A-Ether-Rhein的合成及其坏死亲和性研究[J]. 中国药科大学学报, 2019, 50(4): 444-451. DOI: 10.11665/j.issn.1000-5048.20190409
ZHANG Libang, ZHANG Dongjian, GAO Meng, JIN Qiaomei, WU Tianze, YANG Yang, ZHANG Jian, YIN Zhiqi. Synthesis and evaluation of necrosis avidity of MRI contrast agent Gd-DO3A-Ether-Rhein[J]. Journal of China Pharmaceutical University, 2019, 50(4): 444-451. DOI: 10.11665/j.issn.1000-5048.20190409
Citation: ZHANG Libang, ZHANG Dongjian, GAO Meng, JIN Qiaomei, WU Tianze, YANG Yang, ZHANG Jian, YIN Zhiqi. Synthesis and evaluation of necrosis avidity of MRI contrast agent Gd-DO3A-Ether-Rhein[J]. Journal of China Pharmaceutical University, 2019, 50(4): 444-451. DOI: 10.11665/j.issn.1000-5048.20190409

MRI对比剂Gd-DO3A-Ether-Rhein的合成及其坏死亲和性研究

基金项目: 国家自然科学基金资助项目(No.81771870);江苏省“六大人才高峰”高层次人才项目(YY-011);江苏省自然科学基金资助项目(No.20171512);高层次卫生人才“六个一工程”拔尖人才科研资助项目(No.LGY2018075);双一流学科创新团队资助项目(No.CPU2018GF05,No.CPU2018GY31)

Synthesis and evaluation of necrosis avidity of MRI contrast agent Gd-DO3A-Ether-Rhein

  • 摘要: 以大黄酸为底物、醚链为连接臂合成磁共振成像(MRI)对比剂并评价其坏死亲和性。合成新的配体10-{[6-(1,8-二羟基蒽醌-3-甲酰氨基)乙氧基乙基]氨基}羰酰甲基-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸(DO3A-Ether-Rhein,即E1),再与Gd3+配位得到顺磁性对比剂10-{[6-(1,8-二羟基蒽醌-3-甲酰氨基)乙氧基乙基]氨基}羰酰甲基-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸合钆(Gd-DO3A-Ether-Rhein,即GdE1)。分别在高热诱导的人肝癌HepG2细胞坏死模型和微波消融诱导的大鼠肌肉坏死模型上评价探针的坏死亲和性。动物试验中,分别在给予GdE1(0.1 mmol/kg)前和给药后0~9 h进行MRI成像,Gd-DOTA(1,4,7,10-四乙酸-1,4,7,10-四氮杂环十二烷合钆)作为对照。MRI成像结果表明,坏死细胞的信号强度(4 369±70)显著高于正常细胞(2 555±84)(P<;0.05);在GdE1给药后3 h,坏死肌肉与正常肌肉的对比度为2.00±0.12,显著高于给药后0 h(1.27±0.03)(P<;0.05)。上述结果表明,GdE1具有良好的坏死亲和性,在坏死相关疾病的诊断上显示出良好的应用潜力。
    Abstract: The aim of this study was to synthesize and evaluate the necrosis avidity of MRI contrast agent based on rhein and linked by ether. The novel ligand 10-{[6-(1, 8-dihydroxyanthraquinone-3-carboxamido)ethoxyethyl]amino}carbonylmethyl-1, 4, 7, 10-tetraazacyclododecan-1, 4, 7-triacetic acid(DO3A-Ether-Rhein, E1)was synthesized by two steps of acylation and deprotection reaction. The paramagnetic gadolinium 10-{[6-(1, 8-dihydroxyanthraquinone-3-carboxamido)ethoxyethyl]amino}carbonylmethyl-1, 4, 7, 10-tetraazacyclododecan-1, 4, 7-triacetic acid(Gd-DO3A-Ether-Rhein, GdE1)was obtained by coordination of Gd3+ with the above ligand. We examined the necrotic avidity of GdE1 in human hepatocellular carcinoma HepG2 cell necrosis induced by hyperthermia in vitro and in rat model with muscular necrosis induced by microwave ablation in vivo by MRI. The MRI was implemented before administration of GdE1 and during 0-9 h after administration of GdE1(0. 1 mmol/kg), and Gd-DOTA(gadolinium 1, 4, 7, 10-tetraacetic acid-1, 4, 7, 10-tetraazacyclo dodecane)was used as control. The signal intensity of necrotic cells(4 369±70)was significantly higher than that of normal cells(2 555±84)(P< 0. 05). Similarly, the contrast ratio between necrotic and normal muscle at 3 h after administration of GdE1(2. 00±0. 12)was remarkblely higher than that at 0 h after administration of GdE1(1. 27±0. 03)(P< 0. 05). Therefore, GdE1 presents good necrosis affinity and has the potential to be used in the diagnosis of necrosis-related diseases.
  • [1] Ke B,Tian M,Li J,et al.Targeting programmed cell death using small-molecule compounds to improve potential cancer therapy[J].Med Res Rev,2016,36(6):983-1035.
    [2] Conrad M,Angeli JP,Vandenabeele P,et al.Regulated necrosis:disease relevance and therapeutic opportunities[J].Nat Rev Drug Discov,2016,15(5):348-366.
    [3] Madhuri D, Sungmun L, Jay S, et al. Hoechst-IR:an imaging agent that detects necrotic tissue in vivo by binding extracellular DNA[J].Org Lett,2010,12(15):3300-3303.
    [4] Marie VDP,Marysael T,Fonge H,et al.Radiolabeled iodohypericin as tumor necrosis avid tracer:diagnostic and therapeutic potential[J].Int J Cancer,2012,131(2):129-137.
    [5] Wan L,Pantel K,Kang Y.Tumor metastasis:moving new biological insights into the clinic[J].Nat Med,2013,19(11):1450-1464.
    [6] Siemann DW,Chaplin DJ,Walicke PA.A review and update of the current status of the vasculature disabling agent combretasting-A4 phosphate(CA4P)[J].Expert Opin Investig Drugs,2009,18(2):189-197.
    [7] Park D,Xie BW,Van Beek ER,et al.Optical imaging of treatment-related tumor cell death using a heat shock protein-90 alkylator[J].Mol Pharm,2013,10(10):3882-3891.
    [8] Li JD,Zhang J,Yang SW,et al.Synthesis and preclinical evaluation of radioiodinated hypericin dicarboxylic acid as a necrosis avid agent in rat models of induced hepatic,muscular,and myocardial necroses[J].Mol Pharm,2015,13(1):232-240.
    [9] Wang Q,Yang SW,Jiang CH,et al.Discovery of radioiodinated monomeric anthraquinones as a novel class of necrosis avid agents for early imaging of necrotic myocardium[J].Sci Rep,2016,6:21341.
    [10] Liang JJ,Luo Q,Zhang DJ,et al.SPECT imaging of treatment-related tumor necrosis using technetium-99m-labeled rhein[J].Mol Imaging Biol,2019,21(4):660-668.
    [11] Luo Q,Jin QM,Su C,et al.Radiolabeled rhein as small-molecule necrosis avid agents for imaging of necrotic myocardium[J].Anal Chem,2016,89(2):1260-1266.
    [12] Bian L,Gao M,Zhang DJ,et al.Synthesis and biological evaluation of rhein-based MRI contrast agents for in vivo visualization of necrosis[J].Anal Chem,2018,90(22):13249-13256.
    [13] Bian L,Gao M,Huang DJ,et al.Synthesis and necrosis target of necrosis-avid MRI contrast agent Gd-DO3A-rhein[J].J China Pharm Univ(中国药科大学学报),2017,48(3):282-288.
    [14] Amouroux G,Pan J,Jenni S,et al.Imaging bradykinin B1 receptor with 68Ga-labeled[des-Arg10] kallidin derivatives:effect of the linker on biodistribution and tumor uptake[J].Mol Pharm,2015,12(8):2879-2888.
    [15] Kim YS,Yang CT,Wang J,et al.Effects of targeting moiety,linker,bifunctional chelator,and molecular charge on biological properties of 64Cu-labeled triphenylphosphonium cations[J].J Med Chem,2008,51(10):2971-2984.
    [16] Guo H,Miao Y.Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized alpha-MSH peptide in melanoma[J].J Nucl Med,2014,55(12):2057-2063.
    [17] Glomme A,Marz J,Dressman JB.Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities[J].J Pharm Sci,2005,94(1):1-16.
    [18] Perek N,Sabido O,Le Jeune N,et al.Could 99mTc-glucarate be used to evaluate tumour necrosis?In vitro and in vivo studies in leukaemic tumour cell line U937[J].Eur J Nucl Med Mol Imaging,2008,35(7):1290-1298.
    [19] Ni Y,Chen F,Mulier S,et al.Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor:tissue characterization using a novel necrosis-avid contrast agent[J].Eur Radiol,2006,16(5):1031-1040.
    [20] Mcmurry TJ,Parmelee DJ,Hironao S,et al.The effect of a phosphodiester linking group on albumin binding,blood half-life,and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III)MRI contrast agents[J].J Med Chem,2002,45(16):3465-3474.
    [21] Isaac Z,Avi W,Yoram C.Target-specific ligands and gadolinium-based complexes for imaging of dopamine receptors:synthesis,binding affinity,and relaxivity[J].J Org Chem,2013,78(14):7001-7012.
    [22] Liang JJ,Sun ZP,Zhang DJ,et al.First evaluation of radioiodinated flavonoids as necrosis-avid agents and application in early assessment of tumor necrosis[J].Mol Pharm,2017,15(1):207-215.
计量
  • 文章访问数:  478
  • HTML全文浏览量:  2
  • PDF下载量:  739
  • 被引次数: 0
出版历程
  • 刊出日期:  2019-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭